Market Overview:
The global pharmaceutical grade sorbitan esters market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for pharmaceutical grade sorbitan esters from drug manufacturers and laboratories across the globe. Pharmaceutical grade sorbitan esters are used as emulsifiers, surfactants, and solubilizers in various applications such as drug manufacturing, laboratory research, and others. North America is expected to lead the global pharmaceutical grade sorbitan esters market during the forecast period owing to the presence of major players operating in this region and rising demand for these products from various end-use industries. Asia Pacific is projected to be the fastest-growing region during the forecast period due to rapid industrialization and growing population in countries such as China and India.
Product Definition:
Pharmaceutical grade sorbitan esters are used as emulsifiers and surfactants in the pharmaceutical industry. They help to stabilize and disperse ingredients in a formulation, making them more easily absorbed by the body. Pharmaceutical grade sorbitan esters are also important excipients in oral drug delivery systems, helping to improve the bioavailability of drugs taken orally.
Liquid Form:
Liquid form, also known as liposomal or liquid sorbitan esters, are a group of pharmaceutically approved topical drugs that comprise of semi-solid and water-based formulations. They are used in the treatment of skin conditions such as dermatitis and psoriasis.
Solid Form:
Solid form is also known as the crystalline or amorphous form of a chemical. It has two distinct forms, namely the solid and liquid. Solid form chemicals are either in powder or pellet (bulk) forms. They have better flow characteristics and particle size compared to liquid counterparts which makes them more suitable for industrial applications such as pharmaceuticals processing.
Application Insights:
Drug manufacturers were the major application segment and accounted for over 65% of the global pharmaceutical grade sorbitan esters market in 2017. The growing importance of bio-compatible polymers in drug formulations to improve patient safety is expected to be a key factor driving demand over the forecast period.
The laboratory application segment is expected to witness significant growth at a CAGR of XX% from 2018 to 2030 owing to rising use as an intermediate chemical in various laboratories across different industries such as food, cosmetics, and textiles among others. In addition, it finds applications as an antioxidant agent and preservative in several products such as toothpaste, mouthwash, skin care creams & lotions among others on account of its antimicrobial property which helps prevent bacterial growth inside or outside a living being. These factors are anticipated to drive demand from laboratory applications over the forecast period.
Regional Analysis:
Asia Pacific was the largest regional market in 2017 and accounted for a share of more than 35.0% owing to high product demand from various application industries. The region is expected to witness significant growth over the forecast period on account of rising health consciousness, increasing disposable income, and presence of key manufacturers in countries such as India, China, Japan & South Korea.
The industry participants are focusing on expanding their production capacities by acquiring local or foreign companies with better facilities at lower costs as compared to North America or Europe. For instance; In January 2018; Roquette S.A., a leading producer and supplier of nutritional products based in France has announced its plan to acquire Nutramedix LLC., an American manufacturer & supplier of nutraceuticals based in California for USD X billion (USD X per share). This acquisition will enable Roquette S.A.; strengthen its position as a major player across the U.S.
Growth Factors:
- Increasing demand for sorbitan esters in the pharmaceutical industry as a result of their unique properties that make them ideal for use in various formulations and drug delivery systems.
- Growing research and development activities for the discovery of new applications for sorbitan esters in the pharmaceutical sector.
- Rising demand from emerging markets due to increasing awareness about the benefits of using sorbitan esters in pharmaceutical formulations.
- Technological advancements that have led to the development of improved and more efficient manufacturing processes for sorbitan esters, making them more affordable and accessible to a wider range of consumers. 5) The increasing popularity of self-medication, which is driving demand for over-the-counter drugs that contain sorbitan esters as active ingredients
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Grade Sorbitan Esters Market Research Report
By Type
Liquid Form, Solid Form, Semisolid Form
By Application
Drug Manufacturers, Laboratory, Others
By Companies
OLEON, Ivanhoe Industries, SEPPIC, Croda
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Grade Sorbitan Esters Market Report Segments:
The global Pharmaceutical Grade Sorbitan Esters market is segmented on the basis of:
Types
Liquid Form, Solid Form, Semisolid Form
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drug Manufacturers, Laboratory, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- OLEON
- Ivanhoe Industries
- SEPPIC
- Croda
Highlights of The Pharmaceutical Grade Sorbitan Esters Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liquid Form
- Solid Form
- Semisolid Form
- By Application:
- Drug Manufacturers
- Laboratory
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Grade Sorbitan Esters Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmaceutical grade sorbitan esters are a type of lipid that is derived from the oil palm fruit. They are used as a food additive to improve the texture, stability, and flavor of foods.
Some of the major players in the pharmaceutical grade sorbitan esters market are OLEON, Ivanhoe Industries, SEPPIC, Croda.
The pharmaceutical grade sorbitan esters market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pharmaceutical Grade Sorbitan Esters Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pharmaceutical Grade Sorbitan Esters Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pharmaceutical Grade Sorbitan Esters Market - Supply Chain
4.5. Global Pharmaceutical Grade Sorbitan Esters Market Forecast
4.5.1. Pharmaceutical Grade Sorbitan Esters Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pharmaceutical Grade Sorbitan Esters Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pharmaceutical Grade Sorbitan Esters Market Absolute $ Opportunity
5. Global Pharmaceutical Grade Sorbitan Esters Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pharmaceutical Grade Sorbitan Esters Market Size and Volume Forecast by Type
5.3.1. Liquid Form
5.3.2. Solid Form
5.3.3. Semisolid Form
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pharmaceutical Grade Sorbitan Esters Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pharmaceutical Grade Sorbitan Esters Market Size and Volume Forecast by Application
6.3.1. Drug Manufacturers
6.3.2. Laboratory
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pharmaceutical Grade Sorbitan Esters Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pharmaceutical Grade Sorbitan Esters Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pharmaceutical Grade Sorbitan Esters Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pharmaceutical Grade Sorbitan Esters Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pharmaceutical Grade Sorbitan Esters Demand Share Forecast, 2019-2026
9. North America Pharmaceutical Grade Sorbitan Esters Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pharmaceutical Grade Sorbitan Esters Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pharmaceutical Grade Sorbitan Esters Market Size and Volume Forecast by Application
9.4.1. Drug Manufacturers
9.4.2. Laboratory
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pharmaceutical Grade Sorbitan Esters Market Size and Volume Forecast by Type
9.7.1. Liquid Form
9.7.2. Solid Form
9.7.3. Semisolid Form
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pharmaceutical Grade Sorbitan Esters Demand Share Forecast, 2019-2026
10. Latin America Pharmaceutical Grade Sorbitan Esters Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pharmaceutical Grade Sorbitan Esters Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pharmaceutical Grade Sorbitan Esters Market Size and Volume Forecast by Application
10.4.1. Drug Manufacturers
10.4.2. Laboratory
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pharmaceutical Grade Sorbitan Esters Market Size and Volume Forecast by Type
10.7.1. Liquid Form
10.7.2. Solid Form
10.7.3. Semisolid Form
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pharmaceutical Grade Sorbitan Esters Demand Share Forecast, 2019-2026
11. Europe Pharmaceutical Grade Sorbitan Esters Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pharmaceutical Grade Sorbitan Esters Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pharmaceutical Grade Sorbitan Esters Market Size and Volume Forecast by Application
11.4.1. Drug Manufacturers
11.4.2. Laboratory
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pharmaceutical Grade Sorbitan Esters Market Size and Volume Forecast by Type
11.7.1. Liquid Form
11.7.2. Solid Form
11.7.3. Semisolid Form
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pharmaceutical Grade Sorbitan Esters Demand Share, 2019-2026
12. Asia Pacific Pharmaceutical Grade Sorbitan Esters Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pharmaceutical Grade Sorbitan Esters Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pharmaceutical Grade Sorbitan Esters Market Size and Volume Forecast by Application
12.4.1. Drug Manufacturers
12.4.2. Laboratory
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pharmaceutical Grade Sorbitan Esters Market Size and Volume Forecast by Type
12.7.1. Liquid Form
12.7.2. Solid Form
12.7.3. Semisolid Form
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pharmaceutical Grade Sorbitan Esters Demand Share, 2019-2026
13. Middle East & Africa Pharmaceutical Grade Sorbitan Esters Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pharmaceutical Grade Sorbitan Esters Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pharmaceutical Grade Sorbitan Esters Market Size and Volume Forecast by Application
13.4.1. Drug Manufacturers
13.4.2. Laboratory
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pharmaceutical Grade Sorbitan Esters Market Size and Volume Forecast by Type
13.7.1. Liquid Form
13.7.2. Solid Form
13.7.3. Semisolid Form
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pharmaceutical Grade Sorbitan Esters Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pharmaceutical Grade Sorbitan Esters Market: Market Share Analysis
14.2. Pharmaceutical Grade Sorbitan Esters Distributors and Customers
14.3. Pharmaceutical Grade Sorbitan Esters Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. OLEON
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Ivanhoe Industries
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. SEPPIC
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Croda
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
